Literature DB >> 16210403

Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion.

Junying Yu1, Maxim A Vodyanik, Ping He, Igor I Slukvin, James A Thomson.   

Abstract

Here, we examine the ability of undifferentiated human embryonic stem cells (hESCs) to reprogram the nuclei of hESC-derived myeloid precursors following cell-cell fusion. Using an OP9 coculture system, we produced CD45+ CD33+ myeloperoxidase+ myeloid precursors from an Oct4-enhanced green fluorescent protein (EGFP) knock-in hESC line and demonstrated that Oct4-EGFP expression was extinguished in these precursors. Upon fusion with undifferentiated hESCs, EGFP expression from the endogenous Oct4 promoter/regulatory region was re-established, ESC-specific surface antigens and marker genes were expressed, and myeloid precursor-specific antigens were no longer detectable. When the hybrid cells were formed into embryoid bodies, upregulation of genes characteristic of the three germ layers and extraembryonic tissues occurred, indicating that the hybrid cells had the potential to differentiate into multiple lineages. Interestingly, the hybrid cells were capable of redifferentiating into myeloid precursors with efficiency comparable with that of diploid hESCs despite their neartetraploid chromosome complement. These results indicate that hESCs are capable of reprogramming nuclei from differentiated cells and that hESC hybrid cells provide a new model system for studying the mechanisms of nuclear reprogramming.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210403     DOI: 10.1634/stemcells.2005-0292

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  29 in total

1.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

2.  H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

Authors:  Hadas Hezroni; Itai Tzchori; Anna Davidi; Anna Mattout; Alva Biran; Malka Nissim-Rafinia; Heiner Westphal; Eran Meshorer
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

Review 3.  Advances in reprogramming somatic cells to induced pluripotent stem cells.

Authors:  Minal Patel; Shuying Yang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 4.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 5.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

6.  Stem cell vaccination against cancer: fighting fire with fire?

Authors:  Thomas P Zwaka
Journal:  Mol Ther       Date:  2010-01       Impact factor: 11.454

Review 7.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 8.  Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.

Authors:  Bhavita Walia; Neeraj Satija; Rajendra Prashad Tripathi; Gurudutta U Gangenahalli
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

9.  Reprogrammed astrocytes with old 'memories' blossom into region-specific neurons.

Authors:  Anuja Ghorpade
Journal:  Protein Cell       Date:  2011-02       Impact factor: 14.870

Review 10.  Patient-specific pluripotent stem cells: promises and challenges.

Authors:  Rouven Müller; Claudia Lengerke
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.